IL6 and neoplasm: Mutations within tumors can play a role in this process; BRAF mutations drive tumor cells to produce pro-inflammatory cytokines like VEGF, IL-10, and IL-6, while at the same time decreasing expression of anti-tumor cytokines such as IL-12 [4].